Correlation Between Spire Global and Vytrus Biotech

Can any of the company-specific risk be diversified away by investing in both Spire Global and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Global and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spire Global and Vytrus Biotech SA, you can compare the effects of market volatilities on Spire Global and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Global with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Global and Vytrus Biotech.

Diversification Opportunities for Spire Global and Vytrus Biotech

-0.73

Correlation Coefficient

Spire Global  Vytrus Biotech

Pay attention - limited upside

The 3 months correlation between Spire and Vytrus is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Spire Global and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Spire Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Global are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Spire Global i.e., Spire Global and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Spire Global and Vytrus Biotech

Given the investment horizon of 90 days Spire Global is expected to under-perform the Vytrus Biotech. In addition to that, Spire Global is 5.29 times more volatile than Vytrus Biotech SA. It trades about -0.05 of its total potential returns per unit of risk. Vytrus Biotech SA is currently generating about 0.25 per unit of volatility. If you would invest  216.00  in Vytrus Biotech SA on December 28, 2024 and sell it today you would earn a total of  60.00  from holding Vytrus Biotech SA or generate 27.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.31%
Values	Daily Returns

Spire Global  vs.  Vytrus Biotech SA

Spire Global

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spire Global has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's forward indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vytrus Biotech SA

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vytrus Biotech SA are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Vytrus Biotech exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spire Global and Vytrus Biotech

The main advantage of trading using opposite Spire Global and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Global position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.

The idea behind Spire Global and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.